{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:35:24Z","timestamp":1794864924240,"version":"4.9.1"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/md.0000000000004002","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T07:24:04Z","timestamp":1467617044000},"page":"e4002","source":"Crossref","is-referenced-by-count":120,"title":["Therapeutic approach to IgG4-related disease"],"prefix":"10.1097","volume":"95","author":[{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belchin","family":"Kostov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihan","family":"Acar-Denizli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20210309","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"R2-36-20210309","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.autrev.2014.08.013","article-title":"The clinical spectrum of IgG4-related disease","volume":"13","author":"Brito-Zeron","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R3-36-20210309","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.mayocp.2015.03.020","article-title":"Diagnostic approach to the complexity of IgG4-related disease","volume":"90","author":"Stone","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"R4-36-20210309","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ"},{"key":"R5-36-20210309","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"R6-36-20210309","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3960\/jslrt.54.95","article-title":"IgG4-related disease: diagnostic methods and therapeutic strategies in Japan","volume":"54","author":"Masaki","year":"2014","journal-title":"J Clin Exp Hematop"},{"key":"R7-36-20210309","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R8-36-20210309","doi-asserted-by":"crossref","first-page":"819","DOI":"10.36076\/ppj.2009\/12\/819","article-title":"Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies","volume":"12","author":"Manchikanti","year":"2009","journal-title":"Pain Physician"},{"key":"R9-36-20210309","first-page":"A133","article-title":"Quality of systematic reviews of observational nontherapeutic studies","volume":"7","author":"Shamliyan","year":"2010","journal-title":"Prev Chronic Dis"},{"key":"R10-36-20210309","first-page":"467","article-title":"GRACE principles: recognizing high-quality observational studies of comparative effectiveness","volume":"16","author":"Dreyer","year":"2010","journal-title":"Am J Manag Care"},{"key":"R11-36-20210309","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ki.2012.382","article-title":"Membranous glomerulonephritis is a manifestation of IgG4-related disease","volume":"83","author":"Alexander","year":"2013","journal-title":"Kidney Int"},{"key":"R12-36-20210309","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1445-5994.2012.02964.x","article-title":"Extra-pancreatic manifestations of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression","volume":"43","author":"Bosco","year":"2013","journal-title":"Intern Med J"},{"key":"R13-36-20210309","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.urology.2013.10.052","article-title":"Immunoglobulin G4-related prostatitis: a case-control study focusing on clinical and pathologic characteristics","volume":"83","author":"Buijs","year":"2014","journal-title":"Urology"},{"key":"R15-36-20210309","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/03009742.2013.822094","article-title":"IgG4-related disease in a Chinese cohort: a prospective study","volume":"43","author":"Chen","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"R16-36-20210309","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/PAS.0b013e318157c068","article-title":"Lymphadenopathy of IgG4-related sclerosing disease","volume":"32","author":"Cheuk","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R17-36-20210309","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pan.2012.03.055","article-title":"Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients","volume":"12","author":"Detlefsen","year":"2012","journal-title":"Pancreatology"},{"key":"R18-36-20210309","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore"},{"key":"R19-36-20210309","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"R20-36-20210309","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/IOP.0b013e31829165ad","article-title":"Radiographic patterns of orbital involvement in IgG4-related disease","volume":"29","author":"Ginat","year":"2013","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R21-36-20210309","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2559.2011.04089.x","article-title":"Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions","volume":"60","author":"Go","year":"2012","journal-title":"Histopathology"},{"key":"R22-36-20210309","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"key":"R23-36-20210309","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2169\/internalmedicine.53.1342","article-title":"Incidence of malignancies in patients with IgG4-related disease","volume":"53","author":"Hirano","year":"2014","journal-title":"Intern Med"},{"key":"R24-36-20210309","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/ajg.2014.223","article-title":"Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort","volume":"109","author":"Huggett","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R25-36-20210309","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.11102250","article-title":"Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients","volume":"261","author":"Inoue","year":"2011","journal-title":"Radiology"},{"key":"R26-36-20210309","doi-asserted-by":"crossref","first-page":"401890","DOI":"10.1155\/2012\/401890","article-title":"IgG4-related perineural disease","volume":"2012","author":"Inoue","year":"2012","journal-title":"Int J Rheumatol"},{"key":"R27-36-20210309","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1507\/endocrj.EJ14-0078","article-title":"Analysis of pancreatic endocrine function in patients with IgG4-related diseases, in whom autoimmune pancreatitis was ruled out by diagnostic imaging","volume":"61","author":"Ito","year":"2014","journal-title":"Endocr J"},{"key":"R28-36-20210309","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00535-010-0317-2","article-title":"Serum IgG4-negative autoimmune pancreatitis","volume":"46","author":"Kamisawa","year":"2011","journal-title":"J Gastroenterol"},{"key":"R29-36-20210309","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00234-012-1012-1","article-title":"Radiological features of IgG4-related disease in the head, neck, and brain","volume":"54","author":"Katsura","year":"2012","journal-title":"Neuroradiology"},{"key":"R30-36-20210309","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","article-title":"Proposal for diagnostic criteria for IgG4-related kidney disease","volume":"15","author":"Kawano","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"R31-36-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine (Baltimore"},{"key":"R32-36-20210309","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","article-title":"Rethinking Ormond's disease: \u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease","volume":"92","author":"Khosroshahi","year":"2013","journal-title":"Medicine (Baltimore"},{"key":"R33-36-20210309","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5414\/CN107117","article-title":"Comparative clinical manifestations of IgG4- related and IgG4-negative primary tubulointerstitial nephritis","volume":"76","author":"Kim","year":"2011","journal-title":"Clin Nephrol"},{"key":"R34-36-20210309","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.pas.0000164031.59940.fc","article-title":"Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (K\u00fcttner's tumor)","volume":"29","author":"Kitagawa","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R35-36-20210309","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar3810","article-title":"Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance","volume":"14","author":"Kiyama","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R36-36-20210309","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00417-013-2541-y","article-title":"Clinical features of IgG4-related dacryoadenitis","volume":"252","author":"Koizumi","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R37-36-20210309","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archophthalmol.2010.45","article-title":"Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder","volume":"128","author":"Kubota","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R38-36-20210309","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5009\/gnl.2013.7.1.96","article-title":"Clinical characteristics of patients with autoimmune pancreatitis with or without Mikulicz's disease and Mikulicz's disease alone","volume":"7","author":"Kuruma","year":"2013","journal-title":"Gut Liver"},{"key":"R39-36-20210309","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00428-013-1480-7","article-title":"Idiopathic vs. secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease","volume":"463","author":"Laco","year":"2013","journal-title":"Virchows Arch"},{"key":"R40-36-20210309","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00401-010-0746-2","article-title":"IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria","volume":"120","author":"Lindstrom","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R41-36-20210309","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R42-36-20210309","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.dld.2011.03.006","article-title":"Characteristics of autoimmune pancreatitis based on serum IgG4 level","volume":"43","author":"Matsubayashi","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R43-36-20210309","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/resp.12016","article-title":"Immunoglobulin G4-related lung disease: clinicoradiological and pathological features","volume":"18","author":"Matsui","year":"2013","journal-title":"Respirology"},{"key":"R44-36-20210309","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3960\/jslrt.50.129","article-title":"Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement","volume":"50","author":"Matsuo","year":"2010","journal-title":"J Clin Exp Hematop"},{"key":"R45-36-20210309","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar4671","article-title":"Clinical course after corticosteroid therapy in IgG4-related aortitis\/periaortitis and periarteritis: a retrospective multicenter study","volume":"16","author":"Mizushima","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R46-36-20210309","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3109\/00016489.2010.533699","article-title":"IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease","volume":"131","author":"Moteki","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"R47-36-20210309","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/j.1440-1746.2010.06411.x","article-title":"Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma","volume":"25","author":"Oh","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R48-36-20210309","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/lary.22449","article-title":"Clinical and pathological characteristics of IgG4-related sclerosing sialadenitis","volume":"122","author":"Ohta","year":"2012","journal-title":"Laryngoscope"},{"key":"R49-36-20210309","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-230X-13-168","article-title":"IgG4 related disease \u2013 a retrospective descriptive study highlighting Canadian experiences in diagnosis and management","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"R50-36-20210309","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.2011010062","article-title":"Diagnosis of IgG4-related tubulointerstitial nephritis","volume":"22","author":"Raissian","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R51-36-20210309","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ki.2013.191","article-title":"The clinical course of patients with IgG4-related kidney disease","volume":"84","author":"Saeki","year":"2013","journal-title":"Kidney Int"},{"key":"R52-36-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jjcc.2011.07.014","article-title":"Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis-retrospective analysis of 11 case histories","volume":"59","author":"Sakamoto","year":"2012","journal-title":"J Cardiol"},{"key":"R53-36-20210309","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1440-1827.2008.02257.x","article-title":"Ocular adnexal IgG4-related disease has uniform clinicopathology","volume":"58","author":"Sato","year":"2008","journal-title":"Pathol Int"},{"key":"R54-36-20210309","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/modpathol.2012.54","article-title":"Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes","volume":"25","author":"Sato","year":"2012","journal-title":"Mod Pathol"},{"key":"R55-36-20210309","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/modpathol.2012.196","article-title":"Clinicopathologic analysis of IgG4-related skin disease","volume":"26","author":"Sato","year":"2013","journal-title":"Mod Pathol"},{"key":"R56-36-20210309","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/lary.23792","article-title":"Nasal manifestations of immunoglobulin G4-related disease","volume":"123","author":"Suzuki","year":"2013","journal-title":"Laryngoscope"},{"key":"R57-36-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2169\/internalmedicine.50.4321","article-title":"Serial changes of elevated serum IgG4 levels in IgG4-related systemic disease","volume":"50","author":"Tabata","year":"2011","journal-title":"Intern Med"},{"key":"R58-36-20210309","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jbspin.2014.01.010","article-title":"The utility of FDG-PET\/CT and other imaging techniques in the evaluation of IgG4-related disease","volume":"81","author":"Takahashi","year":"2014","journal-title":"Jt Bone Spine"},{"key":"R59-36-20210309","first-page":"775","article-title":"IgG4-related Mikulicz s disease: ultrasonography of the salivary and lacrimal glands for monitoring the efficacy of corticosteroid therapy.","volume":"773-","author":"Takagi","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"R60-36-20210309","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0003489414526844","article-title":"Otologic manifestations of immunoglobulin G4-related disease","volume":"123","author":"Takagi","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R61-36-20210309","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2169\/internalmedicine.49.3038","article-title":"Metachronous extrapancreatic lesions in autoimmune pancreatitis","volume":"49","author":"Takuma","year":"2010","journal-title":"Intern Med"},{"key":"R62-36-20210309","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jhbp.50","article-title":"Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan","volume":"21","author":"Tanaka","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R63-36-20210309","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/02841851003738846","article-title":"Renal lesions associated with autoimmune pancreatitis: CT findings","volume":"51","author":"Triantopoulou","year":"2010","journal-title":"Acta Radiol"},{"key":"R64-36-20210309","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R65-36-20210309","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03009742.2012.761281","article-title":"Clinical features of a new disease concept, IgG4-related thyroiditis","volume":"42","author":"Watanabe","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"R66-36-20210309","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/eye.2014.251","article-title":"Rituximab for the treatment of IgG4-related orbital disease: experience from five cases","volume":"29","author":"Wu","year":"2015","journal-title":"Eye (Lond"},{"key":"R67-36-20210309","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/s10165-012-0786-7","article-title":"Investigations of IgG4-related disease involving the skin","volume":"23","author":"Yamada","year":"2013","journal-title":"Mod Rheumatol"},{"key":"R68-36-20210309","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1136\/annrheumdis-2012-201694","article-title":"Relapse patterns in IgG4-related disease","volume":"71","author":"Yamamoto","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R69-36-20210309","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/keu228","article-title":"Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment","volume":"54","author":"Yamamoto","year":"2015","journal-title":"Rheumatology (Oxford"},{"key":"R70-36-20210309","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/RHU.0b013e31823262d5","article-title":"Risk factors for the recurrence of IgG 4-related sclerosing disease without autoimmune pancreatitis","volume":"17","author":"Yoo","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"R71-36-20210309","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00330-014-3127-8","article-title":"Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors","volume":"24","author":"You","year":"2014","journal-title":"Eur Radiol"},{"key":"R72-36-20210309","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/PAS.0b013e3181bd535b","article-title":"IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases","volume":"33","author":"Zen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R73-36-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine (Baltimore"},{"key":"R74-36-20210309","first-page":"110","article-title":"An inflammatory condition with different faces: immunoglobulin G4-related disease","volume":"74","author":"Karim","year":"2016","journal-title":"Neth J Med"},{"key":"R75-36-20210309","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40463-015-0071-9","article-title":"Immunoglobulin G4-related diseases in the head and neck: a systematic review","volume":"44","author":"Mulholland","year":"2015","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R76-36-20210309","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00535-010-0221-9","article-title":"Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP","volume":"45","author":"Kamisawa","year":"2010","journal-title":"J Gastroenterol"},{"key":"R77-36-20210309","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":"Standard steroid treatment for autoimmune pancreatitis","volume":"58","author":"Kamisawa","year":"2009","journal-title":"Gut"},{"key":"R78-36-20210309","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R79-36-20210309","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R80-36-20210309","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1136\/annrheumdis-2015-207625","article-title":"Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years","volume":"74","author":"Yamamoto","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R81-36-20210309","doi-asserted-by":"crossref","first-page":"259408","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"key":"R82-36-20210309","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2014.199","article-title":"Autoimmunity: basophils in autoimmune and inflammatory diseases","volume":"11","author":"Sharma","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R83-36-20210309","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","article-title":"Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE","volume":"147","author":"Clayton","year":"2014","journal-title":"Gastroenterology"},{"key":"R84-36-20210309","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","article-title":"Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease","volume":"156","author":"Furukawa","year":"2015","journal-title":"Clin Immunol"},{"key":"R85-36-20210309","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/ar4571","article-title":"B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjogren's syndrome: the similarities and differences","volume":"16","author":"Lin","year":"2014","journal-title":"Arthritis Res Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T12:18:29Z","timestamp":1656764309000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201606280-00036"}},"subtitle":["A systematic review"],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":84,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727303228.793528680","asserted-by":"object"}]},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}